Yayın:
Indole‐Chalcone‐Sulfonamide Hybrids: Synthesis and Dual Biological Evaluation as Anticancer and Antioxidant Agents

Sadeleştirilmiş öğe sayfası
dc.contributor.authorCem Yamali
dc.contributor.authorDilek Aksoy
dc.contributor.authorNagihan Faydali
dc.contributor.authorMerve Nenni
dc.contributor.authorGulsen Akalin Ciftci
dc.contributor.authorKaan Küçükoğlu
dc.contributor.orcid0000-0001-8977-9775
dc.date.accessioned2026-05-20T10:16:12Z
dc.date.issued2026-01-01
dc.identifier.doi10.1002/slct.202503713
dc.identifier.issn2365-6549
dc.identifier.issue4
dc.identifier.openalexW7125808973
dc.identifier.urihttps://hdl.handle.net/11421/39671
dc.identifier.urihttps://doi.org/10.1002/slct.202503713
dc.identifier.volume11
dc.language.isoen
dc.relation.ispartofChemistrySelect
dc.rightsrestrictedAccess
dc.subjectCytotoxic T cell
dc.subjectCytotoxicity
dc.subjectCisplatin
dc.subjectCell culture
dc.subjectLead compound
dc.subjectDrug
dc.subjectCancer cell lines
dc.subjectCancer cell
dc.titleIndole‐Chalcone‐Sulfonamide Hybrids: Synthesis and Dual Biological Evaluation as Anticancer and Antioxidant Agents
dspace.entity.typePublication

Dosyalar

Koleksiyonlar

Publications